Effect of irbesartan monotherapy compared with ACE inhibitors and calcium‐channel blockers on patient compliance in essential hypertension patients: A multicenter, open‐labeled, three‐armed study
Nevres Koylan(Istanbul University), Kemalettin Büyüköztürk(Istanbul University), Giray Kabakçı(Hacettepe University), A. Canberk(Istanbul University), Olcay Sağkan(Ondokuz Mayıs University), Esmeray Acartürk, B. Ilerigelen(Istanbul University-Cerrahpaşa), Nail Çağlar(Ankara University), Şali Çaḡlar(Turkish Society of Cardiology), Remzi Önder(Ege University), Sema Güneri(Dokuz Eylül University), Serap Erdine(University of Milan)
Cited by 12
Related Papers
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension
|Lirias|2003|2.6k
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
|Journal of Hypertension|2009|1.7k
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
|Journal of Hypertension|2016|1.4k